The Mitochondrion-STING Axis in An Early Childhood Onset Neurodegenerative Disease
儿童早期发病的神经退行性疾病中的线粒体-STING 轴
基本信息
- 批准号:10297664
- 负责人:
- 金额:$ 46.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAmyotrophic Lateral SclerosisBacteriaBehaviorBiochemicalBiologyBrainCellsCerebellumChronicComplexCongenital DisordersCre driverCytosolDNADataDefectDependenceDevelopmentDevelopmental Delay DisordersDiseaseEmbryoExhibitsExtravasationGenesGeneticGoalsHumanImmuneImmune signalingImmunologyIn SituInflammationInterferonsInternal Ribosome Entry SiteKnock-outKnockout MiceMediatingMendelian disorderMicrocephalyMitochondriaMitochondrial DNAModelingMolecularMolecular GeneticsMotorMusMutationNerve DegenerationNeurodegenerative DisordersNeurogliaNeurologicNeuronsOnline Mendelian Inheritance In ManParkinson DiseasePathologicPathologyPathway interactionsPatientsPharmaceutical PreparationsPurkinje CellsRattusReporterRoleSeizuresSignal PathwaySignal TransductionSpecificityStimulator of Interferon GenesSting InjuryStressTechnologyTherapeuticTimebrain cellcell typeearly childhoodearly onsetinduced pluripotent stem cellinhibitor/antagonistmRNA Expressionmortalitymouse modelnervous system disorderneuron lossneuropathologyresponsesingle cell analysissingle-cell RNA sequencingtargeted treatment
项目摘要
PROJECT SUMMARY
Mitochondria are powerhouses of the cell that are often viewed as bacteria living in the cytosol. Stressed
or damaged mitochondria induce inflammation through activation of multiple innate immune signaling pathways
including the DNA sensing cGAS-STING pathway. We recently showed that deficiency of a cytoplasmic
deglycosylase NGLY1 results in mitochondrial damage and potent activation of the STING pathway. Mutations
in the NGLY1 gene are associated with an early childhood onset neurodegenetive disease with high mortality
and no therapy. We recently established and characterized a Ngly1-deficient mouse model that develop early
onset and progressive deteriorating coordination and motor functions. We also present exciting molecular and
genetic evidence that implicate the mitochondrion-STING axis in neuropathology. The overall goal of this project
is to define the neuro-pathological mechanism of NGLY1-deficiency, with a strong focus on the mechanism of
the mitochondrion-STING axis. Aim 1 will define cell type specificity through genetic and single-cell approaches.
Aim 2 will dissect intracellular signaling pathways in neuronal and glial cells. Aim 3 will evaluate therapies
targeting the mitochondrion-STING axis. Studies proposed here should reveal the central mechanism of the
mitochondrion-STING axis in neuropathology and neurodegeneration, which will have broad implications in many
complex neurogenerative diseases that are affecting millions of people.
项目总结
线粒体是细胞的动力源,通常被视为生活在细胞质中的细菌。强调
或受损的线粒体通过激活多个先天免疫信号通路而引发炎症
包括DNA感知的cGAS-STING通路。我们最近发现了一种细胞质缺陷
脱糖酶NGLY1导致线粒体损伤和刺痛通路的有效激活。突变
NGLY1基因与儿童早期发病的高死亡率神经退行性疾病有关
也不需要治疗。我们最近建立并鉴定了一种早期发育的Nly1缺陷小鼠模型
开始和进行性的协调和运动功能恶化。我们还介绍了令人兴奋的分子和
在神经病理学中涉及线粒体刺轴的遗传证据。这个项目的总体目标是
旨在明确NGLY1缺乏症的神经病理机制,重点探讨NGLY1缺乏症的发病机制
线粒体刺轴。目标1将通过遗传和单细胞方法定义细胞类型特异性。
目标2将剖析神经细胞和神经胶质细胞的细胞内信号通路。AIM 3将评估治疗方法
瞄准线粒体刺轴。这里提出的研究应该揭示出
线粒体刺轴在神经病理和神经退行性变中的作用,这将在许多方面具有广泛的意义
正在影响数百万人的复杂的神经生成性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nan Yan其他文献
Nan Yan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nan Yan', 18)}}的其他基金
Mechanism of STING-mediated Neuropathology in Niemann-Pick Disease
STING 介导的尼曼-皮克病神经病理学机制
- 批准号:
10454283 - 财政年份:2021
- 资助金额:
$ 46.66万 - 项目类别:
Mammalian RNA Exosome in Maintaining Skin Homeostasis and Hair Follicle Immune Privilege
哺乳动物 RNA 外泌体维持皮肤稳态和毛囊免疫特权
- 批准号:
10205886 - 财政年份:2021
- 资助金额:
$ 46.66万 - 项目类别:
Mechanism of STING-mediated Neuropathology in Niemann-Pick Disease
STING 介导的尼曼-皮克病神经病理学机制
- 批准号:
10653132 - 财政年份:2021
- 资助金额:
$ 46.66万 - 项目类别:
Mechanism of STING-mediated Neuropathology in Niemann-Pick Disease
STING 介导的尼曼-皮克病神经病理学机制
- 批准号:
10274942 - 财政年份:2021
- 资助金额:
$ 46.66万 - 项目类别:
The Mitochondrion-STING Axis in An Early Childhood Onset Neurodegenerative Disease
儿童早期发病的神经退行性疾病中的线粒体-STING 轴
- 批准号:
10482351 - 财政年份:2021
- 资助金额:
$ 46.66万 - 项目类别:
The Mitochondrion-STING Axis in An Early Childhood Onset Neurodegenerative Disease
儿童早期发病的神经退行性疾病中的线粒体-STING 轴
- 批准号:
10653215 - 财政年份:2021
- 资助金额:
$ 46.66万 - 项目类别:
Sting Trafficking and Signaling Beyond Interferon
毒刺贩运和干扰素以外的信号传导
- 批准号:
10591495 - 财政年份:2020
- 资助金额:
$ 46.66万 - 项目类别:
Sting Trafficking and Signaling Beyond Interferon
毒刺贩运和干扰素以外的信号传导
- 批准号:
10368072 - 财政年份:2020
- 资助金额:
$ 46.66万 - 项目类别:
RNA Surveillance in B cell by the Mammalian Cytoplasmic RNA Exosome
哺乳动物细胞质 RNA 外泌体对 B 细胞的 RNA 监视
- 批准号:
10041640 - 财政年份:2020
- 资助金额:
$ 46.66万 - 项目类别:
RNA Surveillance in B cell by the Mammalian Cytoplasmic RNA Exosome
哺乳动物细胞质 RNA 外泌体对 B 细胞的 RNA 监视
- 批准号:
10194375 - 财政年份:2020
- 资助金额:
$ 46.66万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 46.66万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 46.66万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 46.66万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 46.66万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 46.66万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 46.66万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 46.66万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 46.66万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 46.66万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 46.66万 - 项目类别:
Fellowship